Integrin and autocrine IGF2 pathways control fasting insulin secretion in β-cells

Area of Science:

• Cell Biology
• Endocrinology
• Molecular Signaling

Background:

• Diabetes is characterized by abnormal insulin secretion, with links between integrin signaling and insulin activity needing further elucidation.
• Understanding how integrin-dependent pathways influence beta-cell function is crucial for diabetes pathophysiology research.

Purpose of the Study:

• To investigate integrin-dependent signaling pathways regulating insulin secretion in beta cells.
• To explore the connection between these pathways and the autocrine regulation of insulin secretion by insulin/insulin-like growth factor (IGF) 2-AKT signaling.

Main Methods:

• Analysis of integrin-containing adhesions and their signaling components (FAK, paxillin) in beta cells under varying glucose conditions.
• Investigation of AKT isoform cooperation and the role of autocrine IGF2 signaling in regulating adhesion phenotypes and insulin secretion.
• Utilized rat primary beta cells and mouse insulinomas for experimental validation.

Main Results:

• Discovered cooperation between AKT isoforms and FAK-dependent signaling in controlling glucose-stimulated insulin secretion (GSIS) and fasting insulin levels.
• Observed distinct adhesion phenotypes: 'starved' phenotype with large adhesions under low glucose, and remodeled adhesions during GSIS.
• Identified specific signaling requirements (AKT2, FAK, ROCK-RhoA, IGF2) for the 'starved' phenotype that limits insulin release during fasting.

Conclusions:

• Integrin-mediated adhesion signaling and AKT isoform activity play critical roles in modulating insulin secretion.
• The 'starved' adhesion phenotype, regulated by specific signaling, prevents excessive insulin release during fasting.
• Dysregulation of IGF2 and adhesion-mediated signaling pathways may underlie the beta-cell dysfunction observed in diabetes.